nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antifolates: The next generation
|
Fleming, Gini F. |
|
1992 |
19 |
6 |
p. 707-719 13 p. |
artikel |
2 |
Author index
|
|
|
1992 |
19 |
6 |
p. 752- 1 p. |
artikel |
3 |
Clinical trials with the topoisomerase I inhibitors
|
Burris, Howard A. |
|
1992 |
19 |
6 |
p. 663-669 7 p. |
artikel |
4 |
Drug discovery and development in the pharmaceutical industry
|
Schacter, Lee P. |
|
1992 |
19 |
6 |
p. 613-621 9 p. |
artikel |
5 |
Introduction: New antitumor drugs in development
|
Weiss, Raymond B. |
|
1992 |
19 |
6 |
p. 611-612 2 p. |
artikel |
6 |
New antimetabolites in the treatment of human malignancies
|
Cheson, Bruce D. |
|
1992 |
19 |
6 |
p. 695-706 12 p. |
artikel |
7 |
New vinca alkaloids and related compounds
|
Budman, Daniel R. |
|
1992 |
19 |
6 |
p. 639-645 7 p. |
artikel |
8 |
Subject index
|
|
|
1992 |
19 |
6 |
p. 752-756 5 p. |
artikel |
9 |
Taxol: The first of the taxanes, an important new class of antitumor agents
|
Rowinsky, Eric K. |
|
1992 |
19 |
6 |
p. 646-662 17 p. |
artikel |
10 |
The anthracyclines: Will we ever find a better doxorubicin?
|
Weiss, Raymond B. |
|
1992 |
19 |
6 |
p. 670-686 17 p. |
artikel |
11 |
The anthrapyrazoles: A new class of compounds with clinical activity in breast cancer
|
Judson, Ian R. |
|
1992 |
19 |
6 |
p. 687-694 8 p. |
artikel |
12 |
The current status of new platinum analogs
|
Christian, Michaele C. |
|
1992 |
19 |
6 |
p. 720-733 14 p. |
artikel |
13 |
The current status of toxicity protectants in cancer therapy
|
Schuchter, Lynn M. |
|
1992 |
19 |
6 |
p. 742-751 10 p. |
artikel |
14 |
The National Cancer Institute: Cancer drug discovery and development program
|
Grever, Michael R. |
|
1992 |
19 |
6 |
p. 622-638 17 p. |
artikel |
15 |
Trans-retinoic acid and related differentiation agents
|
Parkinson, David R. |
|
1992 |
19 |
6 |
p. 734-741 8 p. |
artikel |